Canadian Media Watch
SEE OTHER BRANDS

Fresh news on media and advertising in Canada

Study reveals support, quit tools help in smoking cessation

(MENAFN) A recent clinical trial has shown that providing a range of nicotine replacement options or vaping products combined with behavioral support significantly helps individuals leaving rehabilitation programs remain smoke-free—an achievement that is typically rare in this group.

The study followed more than 360 adults as they exited detox programs, reinforcing growing evidence that consistent assistance and access to various nicotine substitutes can lead to meaningful progress in quitting smoking among people in recovery. This approach may save lives and lessen the substantial health risks related to tobacco use in this vulnerable population, according to a statement released Tuesday by Flinders University in South Australia, which led the research.

Published in the July edition of Lancet Public Health, the study highlighted that "People recovering from substance use are more than twice as likely to smoke as the general population—and far more likely to suffer and die from tobacco-related illness," said Billie Bonevski, the study’s lead author and director of the Flinders Health and Medical Research Institute.

Participants were randomly assigned to receive either a 12-week supply of vaping devices or a mix of nicotine replacement therapy products, including patches, gum, lozenges, inhalers, and mouth sprays. Both groups were provided with behavioral counseling through Quitline services, researchers explained.

MENAFN02072025000045017281ID1109750379


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service